CD24 (ATG-031 Biosimilar) Recombinant Monoclonal Antibody

1. These findings link iNOS to Notch1 signaling in CD24(+)CD133(+) LCSCs through the activation of TACE/ADAM17. PMID: 30297396
2. CD24, a cell surface receptor enriched in both juvenile chondrocytes and human induced pluripotent stem cells-derived chondrocytes, is a regulatory factor in both faster proliferation and resistance to proinflammatory cues in these chondrocyte populations. PMID: 29096706
3. based on our data, the markers CD44 and CD24 do not reflect the features of CSC and unfavorable prognosis and do not clarify the role and clinical significance of the immunophenotype CD44+/CD24-. PMID: 28967636
4. CD24 and CD44 are upregulated in human pancreatic cancer compared to chronic pancreatitis and may be related to the development of pancreatic cancer. PMID: 28659655
5. Both in vitro and in vivo studies show that cells with CD24-knockdown are more sensitive to docetaxel, while CD24-overexpressing cells are more sensitive to doxorubicin PMID: 28418843
6. We believe that CD24 is a key molecule of metastatic progression in the epithelial-mesenchymal-transition phenomenon and a promising therapeutic target for advanced ovarian cancer. PMID: 28440503
7. CD133+CD24lo phenotype defines 5-FU-resistant human colon cancer stem cell-like cells. PMID: 27659530
8. Our results suggest that higher CD24 expression is significantly associated with lower OS rate, lower DFS rate and some clinicopathological factors such as lymph node invasion and TNM stage. This meta-analysis suggested that CD24 is an efficient prognostic factor in breast cancer PMID: 28315505
9. G7mAb was an anti-CD24 antibody. PMID: 28391164
10. CD44 and CD24 collaboratively drive the reprogramming of nasopharyngeal carcinoma cells through STAT3-mediated stemness and epithelial-mesenchymal transition activation PMID: 27521216
11. The increase in CD19+CD24+CD27+ Bregs was closely associated with fasting insulin secretion. PMID: 28440417
12. CD24 induced colorectal cancer angiogenesis in Hsp90-dependent manner and activated STAT3-mediated transcription of VEGF. PMID: 27494878
13. Study have shown that CD24 is highly expressed in a bone metastatic lung cancer cell line, promotes anchorage-independent growth and adhesion in vitro, and that CD24-knockdown suppressed bone metastasis of lung cancer cells in vivo. PMID: 29095550
14. Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells. PMID: 26712693
15. CD44 and CD24 were not found to predict overall survival or disease-free survival in colonic liver metastases. PMID: 29277789
16. CD24+ tumorigenic cells with angiogenic potential were isolated from oral squamous cell carcinomas. PMID: 28344048
17. We have identified CD24 as a novel regulator of inflammatory response in cartilage that is altered during development and aging PMID: 27955675
18. High nuclear CD24 expression in stromal cells is associated with bladder cancer. PMID: 28674079
19. While no obvious role was found for CD24 in the normal development and maintenance of the dopaminergic nigrostriatal system in mice, it may have a role in mediating the neuroprotective aspects of GDNF in this system. PMID: 28182766
20. Expression of CDH1 and CD24 was transcriptionally upregulated by direct binding of HOXA5 to their promoter sequences as demonstrated by luciferase and ChIP analyses PMID: 27157614
21. notochord-specific marker during early intervertebral disc development PMID: 26910849
22. CD24 is a highly sensitive and specific marker of ovarian carcinoma in the differential diagnosis from malignant mesothelioma and reactive mesothelium in effusions. PMID: 27589896
23. These data suggest a significant association of CD24 genetic variants with prostate cancer onset and progression, which provides new insight into molecular genetics of prostate cancer. PMID: 27377469
24. Data show that CD44bright/CD24dim and CD44bright/CD24bright correspond to epithelioid and fibroblastoid subsets, respectively. PMID: 28121626
25. CD24 cell surface expression may serve as a valuable biomarker in order to identify mammary tumors that will positively respond to targeted IGF1R therapies. PMID: 27179633
26. co-expression of CD90 and CD24 may have an important role in the development and progression of pancreatic intraepithelial neoplasia. PMID: 27332878
27. CD24 expression level directly affects cisplatin sensitivity and affects the expression of critical apoptotic, stem and drug resistance genes. PMID: 27276062
28. CD44+/24- and ALDH1-positive rates in primary tumors differed according to intrinsic subtype. ER-positive patients with CD44+/24- tumors had significantly longer disease-free-survival than all other ER-positive patients PMID: 27768764
29. CD44+/CD24- cells were present in all tumor tissues. The percentage of CD44+/CD24- cells was higher in early-stage disease, but without statistical significance. PMID: 27837613
30. Increased expression of CD24 may be associated with tumor progression and prognosis in patients with uterine cervical cancer. PMID: 26351781
31. High CD24 expression is associated with breast neoplasms. PMID: 27470135
32. The early stage of root development demonstrated higher CD24 expressing cells than later stage. In conclusion, quantity of CD24 expressing cells influenced SCAPs self-renewal and multi-lineage differentiation but did not influence on cell proliferation. PMID: 27613575
33. These results reveal the underlying link between the HCC processes mediated by CD24. Moreover, as a clear tumor promoter, CD24 is considered a potential new target for HCC treatment. PMID: 26608371
34. Of the 66 apocrine lesions, 62 (94 %) did not express C-KIT compared to 4/63 (6 %) of the normal glands PMID: 27287269
35. In this work, we analyzed the expression of CD133, FOXP3, ABCG2 and CD24 in women affected by vulvar cancer, correlating these with common clinical prognostic factors PMID: 27798870
36. The P-534 site in CD24 gene affects the overall survival of gastric cancer and may serve as a prognostic marker for gastric cancer. PMID: 26900300
37. Discussion of the roles of CD24 including the effects of CD24 gene polymorphisms on the risk of developing autoimmune diseases (review). PMID: 25666875
38. our results suggest that CD24 is upregulated in cervical cancer tissues and plays its functions by affecting the MAPK signaling pathway in cervical cancer. PMID: 26707501
39. The frequencies of CD19+CD24hiCD38hi B-regulatory lymphocyte were significantly increased in children with beta-thalassemia. PMID: 26852663
40. CD24 regulates EGFR signaling by inhibiting EGFR internalization and degradation in a RhoA-dependent manner in gastric cancer cells. PMID: 26830684
41. Suggest CD24 expression as independent prognostic factor in colorectal carcinoma. PMID: 26097606
42. CD44(+)/CD24(-) phenotype may be an important factor for malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma. PMID: 26617852
43. we present evidence that CD44v3 immunoexpression and CD44v3+/CD24- immunophenotypes could give prognostic information associated with unfavorable clinical outcomes. PMID: 26647656
44. Increased CD24 gene expression is associated with pediatric medulloblastomas. PMID: 25820321
45. The functional CD24 A57V and TG/del polymorphisms are associated with susceptibility to multiple autoimmune diseases. (Meta-analysis) PMID: 26718436
46. Basal like tumors are enriched for cancer stem cells (CSC) with CD44(+)/CD24(-/low) phenotype. CD133 can detect a different population of CSC in breast carcinoma PMID: 26298632
47. The CD24-positive phenotype is associated with cisplatin resistance in endometrial cancer tumor xenografts and is accompanied by high expression of ABC transporters. PMID: 26227486
48. Reduced CD24 expression decreases oxidative stress and genomic instability. PMID: 25641732
49. CD24 A1626 G is more frequent in OLP patients, contributes to disease risk, and could play a role in OLP susceptibility. PMID: 26187149
50. CD24 gene expression was associated with histone acetylation. PMID: 26444008

Show More

Hide All

HGNC: 1645

OMIM: 126200

KEGG: hsa:100133941

UniGene: Hs.644105